PFS
HQL

Prospera Financial Services’s abrdn Life Sciences Investors HQL Stock Holding History

Prospera Financial Services’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-300
Closed -$4K – 1175
2022
Q2 		$4K Sell
300
-706
-70% -$10.7K ﹤0.01% 1477
2022
Q1 		$17K Buy
+1,006
New +$17.3K ﹤0.01% 1799
2020
Q4 		– Sell
-300
Closed -$5K – 1060
2020
Q3 		$5K Buy
+300
New +$5.37K ﹤0.01% 1284

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Prospera Financial Services's HQL Position: Q3 2022 in Review

Prospera Financial Services sold out of abrdn Life Sciences Investors (HQL) in Q3 2022, closing a stake of 300 shares — an estimated $4K sold.

Prospera Financial Services first reported a position in HQL in Q3 2020 and held it in 3 quarters. The position peaked at $17K in Q1 2022. 63 funds tracked by Wall St. Rank hold HQL as of Q3 2022.

  • Prospera Financial Services reported no remaining abrdn Life Sciences Investors position as of Q3 2022 after selling out during the quarter.
  • Prospera Financial Services sold 300 abrdn Life Sciences Investors shares in Q3 2022, an estimated $4K.
  • Prospera Financial Services first reported a position in abrdn Life Sciences Investors in Q3 2020 and held it in 3 quarters.
  • Prospera Financial Services's abrdn Life Sciences Investors position peaked at $17K in Q1 2022.
  • 63 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2022.

Based on Prospera Financial Services's 13F filing for Q3 2022, filed 27 Oct 2022.